EUVIMEDOpdag EUVIMED
Open access · CC BY-NC 4.0

A gene expression control technology for cell‐free systems and synthetic cells via targeted gene silencing and transfection

Wakana Sato, Melanie Rasmussen, Nathaniel Gaut, Mahima Devarajan, Kaitlin Stokes, Christopher Deich, Aaron E Engelhart, Katarzyna P Adamala iD

Biotechnology and Bioengineering · 2023

DOI: 10.1002/bit.28422 ↗

At a glance

Journal article in Biotechnology and Bioengineering, 2023. Written by Wakana Sato and 7 co-authors. Institution: Department of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, Minnesota, USA. Major MEDLINE topics: Protein Biosynthesis, Artificial Cells. Cited 5 times so far (Crossref); 34 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: National Aeronautics and Space Administration.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Synthetic cells, expressing proteins using cell‐free transcription‐translation (TXTL), is a technology utilized for a variety of applications, such as investigating natural gene pathways, metabolic engineering, drug development or bioinformatics. For all these purposes, the ability to precisely control gene expression is essential. Various strategies to control gene expression in TXTL have been developed; however, further advancements on gene‐specific and straightforward regulation methods are still needed. Here, we present a method of control of gene expression in TXTL using a “silencing oligo”: a short oligonucleotide, designed with a particular secondary structure, that binds to the target messenger RNA. We demonstrated that silencing oligo inhibits protein expression in TXTL in a sequence‐dependent manner. We showed that silencing oligo activity is associated with RNase H activity in bacterial TXTL. To complete the gene expression control toolbox for synthetic cells, we also engineered a first transfection system. We demonstrated the transfection of various payloads, enabling the introduction of RNA and DNA of different lengths to synthetic cell liposomes. Finally, we combined the silencing oligo and the transfection technologies, demonstrating control of gene expression by transfecting silencing oligo into synthetic minimal cells.

Subjects

MeSH terms (MEDLINE)

Protein BiosynthesisArtificial CellsEscherichia coliCell-Free SystemTransfectionGene SilencingRNA, Small Interfering

Author keywords

gene regulationsynthetic biologysynthetic cellstransfection

Substances

RNA, Small Interfering

Authors and institutions

  • Department of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, Minnesota, USA.

ORCID profiles: Katarzyna P Adamala

Funding

  • National Aeronautics and Space Administration

Cite

APA

Sato, W., Rasmussen, M., Gaut, N., Devarajan, M., Stokes, K., Deich, C., Engelhart, A. E., & Adamala, K. P. (2023). A gene expression control technology for cell‐free systems and synthetic cells via targeted gene silencing and transfection. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.28422

Vancouver

Sato W, Rasmussen M, Gaut N, Devarajan M, Stokes K, Deich C, et al. A gene expression control technology for cell‐free systems and synthetic cells via targeted gene silencing and transfection. Biotechnology and Bioengineering. 2023. doi:10.1002/bit.28422

BibTeX
@article{Sato2023,
  author = {Sato, Wakana and Rasmussen, Melanie and Gaut, Nathaniel and Devarajan, Mahima and Stokes, Kaitlin and Deich, Christopher and Engelhart, Aaron E and Adamala, Katarzyna P},
  title = {A gene expression control technology for cell‐free systems and synthetic cells via targeted gene silencing and transfection},
  journal = {Biotechnology and Bioengineering},
  year = {2023},
  doi = {10.1002/bit.28422}
}
Start for free →